| Filed On | Filing |
|---|---|
| 29 Jan 2024 |
Form 4: Arena Pharmaceuticals Inc, Former 10% Owner · Longboard Pharmaceuticals, Inc.
Sold 3,978,540 shares ($96.5M) |
| 11 Mar 2022 |
Form 4: Nova Tina Susan, Director
Disposed of 20,843 shares (Other Transaction) · Disposed of 42,002 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Fetzer Oliver, Director
Disposed of 9,692 shares (Other Transaction) · Disposed of 48,869 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Gallahue Kieran, Director
Disposed of 12,911 shares (Other Transaction) · Disposed of 24,285 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Knobil Katharine, Director
Disposed of 6,821 shares (Other Transaction) · Disposed of 14,702 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Jarrett Jennifer, Director
Disposed of 11,217 shares (Other Transaction) · Disposed of 44,702 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Neil Garry Arthur, Director
Disposed of 11,217 shares (Other Transaction) · Disposed of 48,869 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Schoch Steven J, Director
Disposed of 4,600 shares (Other Transaction) · Disposed of 10,803 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Dallas Jayson Donald Alexander, Director
Disposed of 7,152 shares (Other Transaction) · Disposed of 48,869 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Ouzren Nawal, Director
Disposed of 4,555 shares (Other Transaction) · Disposed of 11,368 Stock Option (right to buy) (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Manion Douglas J., EVP Research & Development
Disposed of 36,462 shares (Other Transaction) · Disposed of 90,000 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 15,200 Employee Performance Restricted Stock Unit (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Stelzer Laurie, EVP & Chief Financial Officer
Disposed of 37,208 shares (Other Transaction) · Disposed of 170,850 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 15,200 Employee Performance Restricted Stock Unit (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Munshi Amit, Director
Gave 10,500 shares as a gift ($1.03M) · Disposed of 114,897 shares (Other Transaction) · Disposed of 1,228,000 Employee Stock Option (right to buy) (Disposition to Issuer) · 1 more |
| 11 Mar 2022 |
Form 4: Schmidt Joan, EVP, General Counsel & Sec
Disposed of 36,287 shares (Other Transaction) · Disposed of 170,850 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 15,200 Employee Performance Restricted Stock Unit (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Aurentz Vincent, Executive VP and CBO
Disposed of 55,964 shares (Other Transaction) · Disposed of 400,826 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 15,200 Employee Performance Restricted Stock Unit (Disposition to Issuer) |
| 11 Mar 2022 |
Form 4: Lisicki Robert, EVP, Chief Commercial Officer
Disposed of 37,563 shares (Other Transaction) · Disposed of 293,850 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 15,200 Employee Performance Restricted Stock Unit (Disposition to Issuer) |
| 05 Jan 2022 |
Form 4: Schmidt Joan, EVP, General Counsel & Sec
Received 21,462 shares as a grant or award |
| 05 Jan 2022 |
Form 4: Manion Douglas J., EVP Research & Development
Received 21,462 shares as a grant or award |
| 05 Jan 2022 |
Form 4: Munshi Amit, Director
Received 85,847 shares as a grant or award |
| 05 Jan 2022 |
Form 4: Stelzer Laurie, EVP & Chief Financial Officer
Received 21,462 shares as a grant or award |
Loading...
